Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | BAX | Q07812 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 2/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.30 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | KDM1A | O60341 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20524986 | 0.87 | CYP2A6 (0.32) | TSHRALDH1A1 | |
| SCHEMBL8130656 | 0.85 | CYP2A6 (0.39) | LTA4HTSHRKDM4EMAPTALDH1A1 | |
| SCHEMBL328940 | 0.85 | LTA4H (0.39) | LTA4HTSHRKDM4EGLAMAPT | |
| SCHEMBL8125384 | 0.81 | — | — | |
| SCHEMBL8124707 | 0.81 | LMNA (0.46) | LTA4HKMT2AHTTALDH1A1LMNA | |
| SCHEMBL328744 | 0.80 | HPRT1 (0.42) | LTA4HTSHRKDM4EGLAMAPT | |
| SCHEMBL3237917 | 0.79 | CA1 (0.30) | CA1CA2 | |
| SCHEMBL15874755 | 0.78 | — | — | |
| SCHEMBL4720994 | 0.76 | RAB9A (0.38) | TSHRKDM4EMAPTKMT2AHTT | |
| SCHEMBL6538521 | 0.75 | KCNA3 (0.52) | LTA4HALDH1A1CYSLTR2CYSLTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115385956-A | Biaryl diphosphine ligands and transition metal complexes thereof | 东莞市均成高新材料有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-115385957-A | Linear terphenyl aryl phosphine ligand and transition metal complex thereof | 东莞市均成高新材料有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-115385955-A | Tetrabiarylphosphine ligands and transition metal complexes thereof | 东莞市均成高新材料有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-115181128-A | Phosphine ligand of arylmethyl biaryl and transition metal complex thereof | 东莞市均成高新材料有限公司 | 2022-10-14 | — | — | CN | claimed |
| US-8900725-B2 | Dendrimer and organic light-emitting device using the same | SAMSUNG DISPLAY CO., LTD. | 2014-12-02 | — | — | US | claimed |
| US-8865322-B2 | Dendrimer and organic light-emitting device using the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2014-10-21 | — | — | US | claimed |
| EP-2407501-B1 | Dendrimer and organic light-emitting device using the same | SAMSUNG DISPLAY CO LTD (KR) | 2013-09-11 | — | — | EP | claimed |
| EP-2407502-B1 | Dendrimer and organic light-emitting device using the same | SAMSUNG DISPLAY CO LTD (KR) | 2013-06-19 | — | — | EP | claimed |
| CN-102432844-A | Dendrimer and organic light-emitting device using the same | SAMSUNG MOBILE DISPLAY CO LTD | 2012-05-02 | — | — | CN | claimed |
| CN-102372662-A | Dendrimer and organic light-emitting device using the same | SAMSUNG MOBILE DISPLAY CO LTD | 2012-03-14 | — | — | CN | claimed |
| EP-1921082-A1 | Silanylamine-based compound, method of preparing the same and organic light emitting device including organic layer comprising the silanylamine-based compound | Samsung SDI Co., Ltd. (KR) | 2008-05-14 | — | — | EP | claimed |
| US-20080106188-A1 | SILANYLAMINE-BASED COMPOUND, METHOD OF PREPARING THE SAME AND ORGANIC LIGHT EMITTING DEVICE INCLUDING ORGANIC LAYER COMPRISING THE SILANYLAMINE-BASED COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2008-05-08 | — | — | US | claimed |
| US-6723718-B2 | GLUTAMATERGIC ANTAGONIST AND AGONISTS; ANTIISCHEMIC AND ANTISPASMODIC AGENTS; BRAIN AND NERVOUS SYSTEM DISORDERS; TRAUMA | BAYER AKTIENGESELLSCHAFT (DE) | 2004-04-20 | — | — | US | claimed |
| US-20030158424-A1 | Substituted alpha, beta-anellated butyrolactones | STOLLE ANDREAS (DE) | 2003-08-21 | — | — | US | claimed |
| US-6462074-B1 | Substituted α, β-anellated butyrolactones | BAYER AKTIENGESELLSCHAFT (DE) | 2002-10-08 | — | — | US | claimed |
| EP-1047684-B1 | SUBSTITUTED ALPHA,BETA-ANELLATED BUTYROLACTONES | BAYER AG (DE) | 2002-10-02 | — | — | EP | claimed |
| US-6376539-B1 | ANTIISCHEMIC AGENTS, CENTRAL NERVOUS SYSTEM DISORDERS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-04-23 | — | — | US | claimed |
| EP-1047684-A1 | SUBSTITUTED ALPHA,BETA-ANELLATED BUTYROLACTONES | BAYER AG (DE) | 2000-11-02 | — | — | EP | claimed |
| WO-1999036416-A1 | SUBSTITUTED α,β-ANELLATED BUTYROLACTONES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-07-22 | — | — | WO | claimed |
| US-4675316-A | FUNGICIDES | ROHM AND HAAS COMPANY (US) | 1987-06-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080106188-A1 | SILANYLAMINE-BASED COMPOUND, METHOD OF PREPARING THE SAME AND ORGANIC LIGHT EMITTING DEVICE INCLUDING ORGANIC LAYER COMPRISING THE SILANYLAMINE-BASED COMPOUND | ICMT, SLC43A1, SLC7A5 | LTA4H 174/4885TSHR 4750/4885KDM4E 2673/4885 |
| US-20030158424-A1 | Substituted alpha, beta-anellated butyrolactones | GABRB2, GABRB3, GABRB1 | LTA4H 1328/4885TSHR 4561/4885KDM4E 3559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.